-
Mashup Score: 1
Click on the article title to read more.
Source: Wiley Online LibraryCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 5
Background In the olfactory epithelium, mitotically active globose basal cells (GBCs) continuously replenish olfactory sensory neurons (OSNs) lost throughout life. Although an essential role of the …
Source: Wiley Online LibraryCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 4Scope It Out - 3 year(s) ago
A podcast series exploring methods & breakthroughs in the fields of allergy & rhinology and select articles from International Forum of Allergy & Rhinology.
Source: Scope It OutCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 5Online Event - 3 year(s) ago
June 24th, 8pm EDTalready registered…click here.The 2021 update of ICAR: Rhinosinusitis has been recently published in the International Forum of Allergy and Rhinology and many are asking “What do we need to know?” Please join us for a live, interactive Rhinocast June 24 at 8 pm jointly sponsored by AAOA and ARS and produced by Wiley, where we will be featuring key content creators and subject…
Source: www.workcast.comCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Seeking clues to mysteries of coronavirus by studying a person’s ability to taste bitterness - 3 year(s) ago
An ENT doctor and his team are among thousands of researchers confronting the pandemic. They hope their work will provide a better way to fight covid-19.
Source: Washington PostCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Click on the article title to read more.
Source: Wiley Online LibraryCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 3Botulinum toxin for chronic rhinitis: A systematic review and meta-analysis - PubMed - 3 year(s) ago
BTX-A improved TNSS and QOL in patients with chronic rhinitis. These effects were demonstrated up to 24 weeks post treatment. BTX-A was safe, well tolerated, and may be considered in patients who are refractory to current standard-of-care therapies.
Source: PubMedCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Background Botulinum toxin type A (BTX‐A) is a potential treatment for chronic rhinitis. This study aimed to assess the effectiveness and safety of BTX‐A in treating patients with chronic rhinitis. …
Source: Wiley Online LibraryCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0HPV in the malignant transformation of sinonasal inverted papillomas: A meta‐analysis - 3 year(s) ago
Objectives : To date, there is still a significant debate on the role of human papilloma virus (HPV) infection in transformation of inverted papillomas (IPs) to squamous cell carcinoma (SCC). This s…
Source: Wiley Online LibraryCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view - 3 year(s) ago
The frequent association between coronavirus disease 2019 (COVID‐19) and olfactory dysfunction is creating an unprecedented demand for a treatment of the olfactory loss. Systemic corticosteroids have…
Source: Wiley Online LibraryCategories: Allergy-Immunology, Latest HeadlinesTweet
Population database study on #epidemiology and #outcomes of Acute invasive fungal sinusitis with a 23.5% mortality https://t.co/HQ94sRGoKB @DrShintaniSmith @airway_doc